Drug addiction is not an independent risk factor for oncogenic human papillomavirus infections or high-grade cervical intraepithelial neoplasia: Case-control study nested within the Latin American Screening study cohort

International Journal of STD and AIDS

Volumn 19, Issue 4, 2008, Pages 251-258

  Syrjänen, Kari ^a   Naud, P ^b   Derchain, S ^c   Roteli Martins, C ^d   Longatto Filho, A ^e,f   Tatti, S ^g   Branca, M ^h   Erzen M ⁱ   Hammes, L S ^b   Matos, J ^b   Gontijo, R ^c   Sarian, L ^c   Braganca J ^c   Arlindo, F C ^d   Maeda, M Y S ^e,f   Lorincz A ^j   Dores, G B ^k   Costa, S ^l   Syrjanen S ^m  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d HOSPITAL MATERNIDADE LEONOR MENDES DE BARROS   (Brazil)

^e INSTITUTO ADOLFO LUTZ   (Brazil)

^f UNIVERSITY OF MINHO   (Portugal)

^g HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^h ISTITUTO SUPERIORE DI SANITÀ   (Italy)

ⁱ SIZE Diagnostic Center   (Slovenia)

^j Digene Corporation   (United States)

^k Digene Brazil   (Brazil)

^l UNIVERSITY OF BOLOGNA   (Italy)

^m UNIVERSITY OF TURKU   (Finland)

more..

Author keywords

Addiction; Case control setting; Cervical cancer; CIN; Conditional logistic regression; Drug abuse; HR HPV; Risk factors; Smoking

Indexed keywords

CANNABIS; COCAINE; DIAMORPHINE; LYSERGIDE; MORPHINE; SOLVENT;

ADOLESCENT; ADULT; AGE; ARTICLE; CANCER GRADING; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NONHUMAN; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SMOKING; UNIVARIATE ANALYSIS; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; VAGINAL SMEARS;

EID: 44349098559     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2007.007179     Document Type: Article

References (30)

1. Syrjänen K, Gissmann L, Koss LG, eds. Papillomaviruses and Human Disease. Berlin, Heidelberg: Springer Verlag, 1987:1-518
2. Syrjänen K, Syrjänen S. Papillomavirus Infections in Human Pathology. New York: John Wiley & Sons, 2000:1-615
3. Cavalcanti SM, Zardo LG, Passos MR, Oliveira LH. Epidemiological aspects of human papillomavirus infection and cervical cancer in Brazil. J Infect 2000;40:80-7
4. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006;24(suppl. 1):S1-15
5. Castellsague X, Munoz N. Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking (Chapter 3). J Natl Cancer Inst Monogr 2003:20-8
6. Kataja V, Syrjänen S, Yliskoski M, et al. Risk factors associated with cervical human papillomavirus infections: a case-control study. Am J Epidemiol 1993;138:735-45
7. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27
8. Campo S, ed. Papillomavirus Research: From Natural History to Vaccines and Beyond. Norwich, UK: Caister Academic Press, 2006:1-424
9. Syrjänen K, Väyrynen M, Castren O, et al. Sexual behaviour of women with human papillomavirus (HPV) lesions of the uterine cervix. Br J Vener Dis 1984;60:243-8
10. Reeves WC, Rawls WE, Brinton LA. Epidemiology of genital papillomaviruses and cervical cancer. Rev Infect Dis 1989;11:426-39
11. Rieck G, Fiander A. The effect of lifestyle factors on gynaecological cancer. Best Pract Res Clin Obstet Gynaecol 2006;20:227-51
12. Marzo Lopez MC, Aguilar Ligorit E, Ramirez Bosca A, Montolio Donate S, Soto Ferrando P, Castells Rodellas A. Study of immunologic parameters in parenteral drug addicts (PDA) with Condylomata acuminata. Med Cutan Ibero Lat Am 1988;16:187-91
13. Conti M, Agarossi A, Parazzini F, et al. HPV, HIV infection, and risk of cervical intraepithelial neoplasia in former intravenous drug abusers. Gynecol Oncol 1993;49:344-8
14. Spinillo A, Tenti P, Baltaro F, Piazzi G, Iasci A, DeSantolo A. Cervical intraepithelial neoplasia in pregnant intravenous drug users infected with human immunodeficiency virus type 1. Eur J Obstet Gyn Reprod Biol 1996;68:175-8
15. Rezza G, Giuliani M, Serraino D, et al. Risk factors for cervical presence of human papillomavirus DNA among women at risk for HIV infection. DIANAIDS Collaborative Study Group. Epidemiol Infect 1998;121:173- 7
16. Goncalves MA, Burattini MN, Donadi EA, Massad E. Risk factors associated with genital warts in HIV-positive Brazilian women. Tumori 2003;89:9-15
17. Dev D, Lo Y, Ho GY, Burk RD, Klein RS. Incidence of and risk factors for genital human papillomavirus infection in women drug users. J Acquir Immune Defic Syndr 2006;41:527-9
18. Feingold AR, Vermund SH, Burk RD, et al. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1990;3:896-903
19. Ho GY, Burk RD, Fleming I, Klein RS. Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer 1994;56:788-92
20. Branca M, Delfino A, Rossi E, et al. Cervical intraepithelial neoplasia and human papillomavirus related lesions of the genital tract in HIV positive and negative women. Eur J Gynaecol Oncol 1995;16:410-7
21. Serraino D, Napoli PA, Zaccarelli M, Alliegro MB, Pezzotti P, Rezza G. High frequency of invasive cervical cancer among female injecting drug users with AIDS in Italy. AIDS 1996;10:1041-2
22. Uberti-Foppa C, Origoni M, Maillard M, et al. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women. J Med Virol 1998;56:133-7
23. de Sanjose S, Valls I, Paz CM, et al. Human papillomavirus and human immunodeficiency virus infections as risk factors for cervix cancer in women prisoners. Med Clin (Barc) 2000;115:81-4
24. Branca M, Garbuglia A-R, Benedetto A, et al. Factors predicting the persistence of genital human papillomavirus (HPV) infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up. Int J STD AIDS 2003;14:417-25
25. Syrjänen K, Naud P, Derchain SM, et al. Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS Study. Anticancer Res 2005;25:3469-80
26. Longatto-Filho A, Maeda MYS, Eržen M, et al. Conventional PAP smear and liquid-based cytology as screening tools in low-resource settings of Latin America. Experience of the Latin American Screening Study. Acta Cytol 2005;49:500-6
27. Sarian L, Derchain SM, Naud P, et al. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI) cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin American Screening) study. J Med Screen 2005;12:142-9
28. Longatto-Filho A, Eržen M, Branca M, et al. Human papillomavirus (HPV) testing as an optional screening tool in low-resource settings of Latin America. Experience from the LAMS Study. Int J Gynecol Cancer 2006;16:955-62
29. Hammes LS, Naud P, Passos E, et al. Value of the International Federation of Colposcopy and Cervical Pathology (IFCPC) terminology in predicting cervical pathology. J Lower Genital Tract Dis 2007;11:158-65
30. dos Santos Silva I. Cancer Epidemiology: Principles and Methods. Lyon: IARC, 1999:305-25